Ann: PAT-DX1 GMP specification testing update, page-28

Herald Sun this morning.
Headline. Brain cancer "revolution."
A cutting edge cancer therapy that trains our immine system to melt tumoursn from witgin could "revolutionise" treatment for an incurable brain cancer that has few other options. Survival rates for gliomas, an aggressive tumour, have barely moved in decades, but, Melbourne researchers hope aa "two in one" therapy that "completely cured" 100% of mice during trials could change this."
WEHI Professor Misty Jenkins said many treatments that succeeded in preclinical trials failed in humans, but these strong results gave her cconfidence."
This therapy not only targeted and killed the cancer cells, but also triggered a long lasting immune response preventing future tumour growth" she said. The team hopes brain cancer patients can trial it within two years. etc. etc.